Ethan Lovell Email

Head Investor Relations . Theravance Biopharma US

Current Roles

Employees:
243
Revenue:
$37.7M
About
Theravance Biopharma is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Our pipeline of internally discovered programs is targeted to address significant patient needs. Our research is focused in the areas of inflammation and immunology. We have one approved product, YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Theravance Biopharma US Address
901 Gateway Blvd.
South San Francisco, CA
United States
Theravance Biopharma US Email

Past Companies

Theravance Biopharma US, Inc.Head of Investor Relations
AgenusChief External Affairs & Communications Officer
University of DenverFull Time Graduate Student

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.